Development of specific immunoassay critical reagents for Pharmacokinetic assessments of peptide polymers in preclinical and clinical matrices

摘要

The present disclosure provides methods of developing a specific immunoassay for the Pharmacokinetic assessments of peptides, peptide oligomer and polymer including Glatiramer Acetate (GA), also known as Copolymer 1, Copolymer- 1, Cop 1 or Cop in the clinical and preclinical matrices.